Globus Medical, Inc. (GMED)

Globus Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	507.75	526.16	784.44	467.29	150.47	193.07
Short-Term Investments	87.4	31.09	105.62	50.5	295.59	250.38
Cash & Short-Term Investments	595.14	557.24	890.06	517.79	446.06	443.45
Cash Growth	159.38%	-37.39%	71.90%	16.08%	0.59%	3.91%
Accounts Receivable	692.18	678.94	557.7	503.24	213.25	164.44
Other Receivables	47.1	64.73	20.63	1.64	4.06	1.22
Receivables	739.28	743.67	578.33	504.87	217.31	165.65
Inventory	810.9	759.28	659.23	848.14	298.98	237
Prepaid Expenses	70.2	65.43	49.64	44.58	21	18.42
Total Current Assets	2,216	2,126	2,177	1,915	983.34	864.52
Property, Plant & Equipment	593.38	628.96	612.07	647.66	249.72	221.08
Long-Term Investments	245.36	71.82	66.13	75.43	495.85	562.48
Goodwill	1,438	1,435	1,432	1,435	197.47	179.71
Other Intangible Assets	692.62	745.06	795.12	924.6	63.57	68.66
Long-Term Deferred Tax Assets	224.63	218.22	94.2	10.69	48.85	24.49
Other Long-Term Assets	78.54	78.06	74.58	77.79	37.32	36.33
Total Assets	5,488	5,303	5,252	5,086	2,076	1,957

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	106.94	98.85	75.12	56.67	36.1	21.96
Accrued Expenses	247.94	281.36	253.61	230.65	86.61	87.24
Current Portion of Long-Term Debt	-	-	443.35	-	-	-
Current Portion of Leases	14.73	15.09	10.48	12.44	2.54	-
Current Income Taxes Payable	6.04	4.16	10.73	3.85	0.99	1.05
Current Unearned Revenue	27.98	27.66	22.14	18.37	14.1	12.03
Other Current Liabilities	75.73	71.39	40.49	70.37	18.87	17.89
Total Current Liabilities	479.35	498.5	855.91	392.35	159.2	140.16
Long-Term Debt	-	-	-	417.4	-	-
Long-Term Leases	97.19	104.35	83.89	91.37	3.48	-
Long-Term Deferred Tax Liabilities	42.34	23.76	23.89	84.42	1.78	4.31
Other Long-Term Liabilities	100.78	102.9	110.73	102.58	65.3	71.4
Total Liabilities	719.66	729.51	1,074	1,088	229.75	215.88

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.13	0.14	0.14	0.14	0.1	0.1
Additional Paid-In Capital	3,230	3,170	3,031	2,871	630.95	553.79
Retained Earnings	1,527	1,388	1,153	1,137	1,240	1,194
Comprehensive Income & Other	11.2	15.35	-6.86	-10.19	-24.63	-6.77
Shareholders' Equity	4,769	4,573	4,177	3,998	1,846	1,741
Total Liabilities & Equity	5,488	5,303	5,252	5,086	2,076	1,957

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	111.91	119.44	537.72	521.22	6.01	-
Net Cash (Debt)	728.59	509.62	418.47	72	935.9	1,006
Net Cash Growth	574.39%	21.78%	481.20%	-92.31%	-6.96%	28.89%
Net Cash Per Share	5.32	3.72	3.04	0.63	9.12	9.71
Filing Date Shares Outstanding	134.26	135.25	137.54	135.37	100.3	101.56
Total Common Shares Outstanding	134.25	135.06	137.42	136.34	100.19	101.54
Working Capital	1,736	1,627	1,321	1,523	824.14	724.35
Book Value Per Share	35.52	33.86	30.40	29.32	18.43	17.15
Tangible Book Value	2,638	2,393	1,950	1,639	1,585	1,493
Tangible Book Value Per Share	19.65	17.72	14.19	12.02	15.82	14.70
Land	10.81	10.85	9.73	9.75	8.28	8.3
Buildings	127.77	127.57	100.13	102.45	51.51	44.67
Machinery	1,095	1,072	956.23	878.41	508.88	443.25

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error